Who owns ABEONA THERAPEUTICS INC?
- Ticker: ABEO
- CUSIP Number: 00289y206
Tip: Access positions for across all investors
Analyze quarterly positions in Abeona Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Abeona Therapeutics stock
Who bought or sold ABEONA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Nantahala Capital Management | 4.0M | $23M | 2% | Dec 2024 |
|
Adage Capital Partners GP | 3.9M | $22M | 20% | Dec 2024 |
|
Suvretta Capital Management | 3.7M | $21M | 0% | Dec 2024 |
|
Millennium Management | 2.1M | $12M | -8% | Dec 2024 |
|
Western Standard | 2.1M | $12M | 23% | Dec 2024 |
|
Vanguard Group | 2.0M | $11M | -2% | Dec 2024 |
|
Vivo Capital | 1.8M | $10M | 0% | Dec 2024 |
|
Rosalind Advisors | 1.8M | $10M | -1% | Dec 2024 |
|
Laurion Capital Management | 1.3M | $7.3M | 0% | Dec 2024 |
|
683 Capital Management | 792k | $4.4M | 17% | Dec 2024 |
|
Propel Bio Management | 624k | $3.9M | -50% | Sep 2024 |
|
Citigroup | 614k | $3.4M | 0% | Dec 2024 |
|
Ikarian Capital | 599k | $3.3M | 3% | Dec 2024 |
|
Susquehanna International | 598k | $3.3M | 290% | Dec 2024 |
|
Walleye Trading Advisors | 586k | $3.3M | -32% | Dec 2024 |
|
BlackRock | 511k | $2.8M | 7% | Dec 2024 |
|
Geode Capital Management | 464k | $2.6M | 0% | Dec 2024 |
|
Simplify Asset Management | 409k | $2.6M | 0% | Sep 2024 |
|
Newtyn Management | 380k | $2.1M | 0% | Dec 2024 |
|
Boothbay Fund Management | 296k | $1.6M | 34% | Dec 2024 |
|
Bank of America Corporation | 264k | $1.5M | 17% | Dec 2024 |
|
Standard Life Aberdeen | 224k | $1.2M | -31% | Dec 2024 |
|
Northern Trust | 185k | $1.0M | 7% | Dec 2024 |
|
State Street Corporation | 184k | $1.0M | 15% | Dec 2024 |
|
Qube Research & Technologies | 162k | $902k | 167% | Dec 2024 |
|
Goldman Sachs Group | 134k | $747k | 100% | Dec 2024 |
|
Jane Street | 132k | $732k | 895% | Dec 2024 |
|
Morgan Stanley | 131k | $729k | -26% | Dec 2024 |
|
Bank of New York Mellon | 122k | $677k | 0% | Dec 2024 |
|
Palo Alto Investors | 109k | $606k | 746% | Dec 2024 |
|
GSA Capital Partners | 107k | $593k | 11% | Dec 2024 |
|
Wellington Management Company | 93k | $520k | 100% | Dec 2024 |
|
Renaissance Technologies | 89k | $497k | -34% | Dec 2024 |
|
Connective Capital Management | 75k | $417k | 0% | Dec 2024 |
|
Trexquant Investment | 69k | $382k | 100% | Dec 2024 |
|
OMERS Administration Corporation | 65k | $362k | 100% | Dec 2024 |
|
UBS Group | 63k | $351k | 100% | Dec 2024 |
|
Schonfeld Strategic Advisors | 61k | $341k | 100% | Dec 2024 |
|
Barclays | 56k | $313k | 2% | Dec 2024 |
|
Marshall Wace | 51k | $286k | -39% | Dec 2024 |
|
LPL Financial | 51k | $283k | -2% | Dec 2024 |
|
Balyasny Asset Management | 34k | $190k | 100% | Dec 2024 |
|
ADAR1 Capital Management | 24k | $154k | -78% | Sep 2024 |
|
Charles Schwab Investment Management | 24k | $133k | 0% | Dec 2024 |
|
CI Private Wealth | 22k | $192.777600 | 0% | Dec 2024 |
|
Oxford Asset Management | 21k | $118k | 100% | Dec 2024 |
|
Leucadia National Corporation | 18k | $100k | 0% | Dec 2024 |
|
Advisor Group Holdings | 14k | $88k | 0% | Dec 2024 |
|
Citadel Advisors | 12k | $68k | -77% | Dec 2024 |
|
Squarepoint Ops | 12k | $67k | 100% | Dec 2024 |
|
Twinbeech Capital | 10k | $58k | 100% | Dec 2024 |
|
Tower Research Capital | 6.0k | $33k | -1% | Dec 2024 |
|
Group One Trading | 4.9k | $27k | 100% | Dec 2024 |
|
Rhumbline Advisers | 1.9k | $10k | 0% | Dec 2024 |
|
Parallel Advisors | 400.00 | $2.2k | 0% | Dec 2024 |
|
SBI Securities | 217.00 | $1.2k | 100% | Dec 2024 |
|
Activest Wealth Management | 120.00 | $668.004000 | 0% | Dec 2024 |
|
Lazard Asset Management | 116.00 | $0 | 0% | Dec 2024 |
|
Truvestments Capital | 51.00 | $283.998600 | 0% | Dec 2024 |
|
Harwood Advisory | 26.00 | $164.000200 | 100% | Sep 2024 |
|
Jpmorgan Chase & Co | 14.00 | $77.999600 | -100% | Dec 2024 |
|
Goss Wealth Management | 1.00 | $6.000000 | 0% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 1.00 | $6.000000 | 100% | Dec 2024 |
|
Who sold out of Abeona Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
XTX Topco | Sep 2024 | 25k | $160k |
Bank Of Montreal | Sep 2024 | 14k | $85k |
Game Plan Financial Advisors | Sep 2024 | 2.4k | $15k |
Wells Fargo & Company | Sep 2024 | 60.00 | $379.002000 |